News
Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...
Here is why Pfizer's newfound momentum could set the stock up to soar in 2026. Pfizer's generous dividend has become a big ...
Chasing a 100 times return might not be a great idea. But there are lessons to be taken from past winners of this magnitude.
Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...
Weekly Trust on MSN12h
Aftermath of vaccine trial: 29 years after: Pfizer vaccine victims speakAs you can see, life has been very difficult for me. I am 30 years old, yet I look like a seven-year-old girl. I can't walk for a distance; and I can't afford to miss a step and fall down because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results